apolipoprotein A-II amyloidosis
ORPHA: 2382691 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Tafamidis Orphan | Oral capsule 20mg, 61mg | FDA Approved | 9 | 10d |
Classification & Codes
Orphanet Code
ORPHA:238269apolipoprotein A-II amyloidosis
| Orphanet | ORPHA:238269 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO